| PUBCHEM ID |
71599291
|
| UNII |
LZI0HJ3K2R
|
| Preferred Term |
CAPROOYL TETRAPEPTIDE-3
|
| CAS |
|
| INCHIKEY |
TVYSZBPKCYVUOM-ULQDDVLXSA-N
|
| Download |
mol2, pdbqt
|
| mol2 |
|
| Smiles |
CCCCCC(NCC(N[C@@H](CCC(N)=O)C(N(CCC1)[C@@H]1C(N[C@@H](CCCN=C(N)N)C(O)=O)=O)=O)=O)=O
|
| Total Surface Area |
434,7
|
| Relative PSA |
0,42924
|
| TPSA |
252,4
|
| cLogS |
-2,566
|
| MW |
554,646
|
| cLogP |
-2,2965
|
| H-Acceptors |
15
|
| H-Donors |
7
|
| Ro5 violations |
3
|
| Druglikeness |
-13,609
|
| DrugScore |
0,193076790113956
|
| Mutagenic |
none
|
| Tumorigenic |
none
|
| Reproductive Effective |
none
|
| Irritant |
high
|
| Blood-Brain Barrier |
BBB-
|
| Human Intestinal Absorption |
HIA+
|
| Caco-2 Permeability I |
Caco2-
|
| Caco-2 Permeability II |
-0,63
|
| P-glycoprotein Substrate |
Substrate
|
| P-glycoprotein Inhibitor I |
Non-inhibitor
|
| P-glycoprotein Inhibitor II |
Non-inhibitor
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Subcellular localization |
Lysosome
|
| CYP450 2C9 Substrate |
Non-substrate
|
| CYP450 2D6 Substrate |
Non-substrate
|
| CYP450 3A4 Substrate |
Non-substrate
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Non-inhibitor
|
| CYP450 3A4 Inhibitor |
Non-inhibitor
|
| CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
| Human Ether-a-go-go-Related Gene Inhibition I |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition II |
Non-inhibitor
|
| AMES Toxicity |
Non AMES toxic
|
| Carcinogens |
Non-carcinogens
|
| Fish Toxicity I |
High FHMT
|
| Fish Toxicity II |
2,0156
|
| Tetrahymena Pyriformis Toxicity I |
High TPT
|
| Tetrahymena Pyriformis Toxicity II |
0,2627
|
| Tetrahymena Pyriformis Toxicity |
Low HBT
|
| Biodegradation |
Not ready biodegradable
|
| Acute Oral Toxicity |
III
|
| Rat Acute Toxicity |
2,3985
|
| Carcinogenicity (Three-class) |
Non-required
|
